Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Outbreak investigation of Visceral Leishmaniasis in Borena Zone, Oromia Region, Ethiopia, November 2019: Case Control study

Belay Regassa, Negussie Deyessa, Adamu Addissie, Abdulnasir Abagero, Gemechu Shumi, Gemechu Gudina
doi: https://doi.org/10.1101/2020.11.02.20222869
Belay Regassa
1Department of Public Health Emergency Management, Oromia Regional Health Bureau, Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: regassabelay{at}gmail.com
Negussie Deyessa
2Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adamu Addissie
2Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulnasir Abagero
2Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gemechu Shumi
1Department of Public Health Emergency Management, Oromia Regional Health Bureau, Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gemechu Gudina
1Department of Public Health Emergency Management, Oromia Regional Health Bureau, Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Visceral Leishmaniasis (VL) caused by Leishmania parasites, infects mammals transmitted by Phlebotomine sand-flies and mostly affects the poorest. VL distributed worldwide and prevalent in Ethiopia. Knowing occurrence of disease and risk factor is a remedy for controlling. The aim of study was to identify factors associated with VL.

Methods Case control study was carried out during October-November 2019 in Borena. A 1:2 Cases and controls were identified by case definition and 33 cases were included in the study. Participants >18years interviewed and caregivers of <18 were questioned for legal issue. Epi-info and SPSS were used for data entry and analysis. Primarily predictors were identified using chi-square at significant level P<0.05 with 95%CI, then candidate predictors were analysed using bivariate and multivariate analysis to identify associated factors.

Result Among 153 suspected cases, 9 suspected deaths reported; 33 (22%) cases and 3 deaths were verified for VL. Among 33 verified cases 15(45.5%) were in July 2019, in comparison of 4years data, there is surge cases in July-August 2019, 26(79%) of cases were from Dire, Attack Rate (AR) = 15/100,000, CFR=9.1%. Among all, 15-64year were highly affected with AR=19.3. A case control engaged 99(100%) respondents and among all 93(93.9%) were male, 68(68.8%) were 15-64years. Adult education Adjusted Odds Ratio (AOR) = 30.438(2.378, 389.602), bed-net AOR=9.024 (1.763, 46.205) and walling AOR=0.052(0.004, 0.739) were associated factors with VL at 95%CI with p-value<0.05.

Conclusion Male 15-64years were highly susceptible. Level of education, ITNs and walling were associated factors with VL. Formulating policies and guidelines for male 15-64 years related vector control and awareness creation regarding feeding habit of sand fly, prevention and control were recommended. Awareness of community on prevention method; using repellents, ITNs utilization, and safe sleeping mechanisms are mandatory. Further investigation on the issue is best remedy to overcome future VL outbreak occurrence.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Addis Ababa University and Oromia Regional Health Bureau have approved the investigation

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Abstract, Result and Figure 6

Data Availability

Raw data of the manuscript and line list of Visceral Leishmaniasis cases

  • Abbreviations

    AOR
    Adjusted Odds Ratio
    AR
    Attack Rate
    CDC
    Centre for Disease Prevention and Control
    CFR
    Case Fatality Rate
    CI
    Confidence Interval
    COD
    Crude Odds Ratio
    FMoH
    Federal Ministry of Health of Ethiopia
    HH
    Household
    ITNs
    Insecticide Treated Nets
    NTD
    Neglected Tropical Diseases
    PHEM
    Public Health Emergency Management
    RHB
    Regional Health Bureau
    VL
    Visceral Leishmaniasis
    WHO
    World Health Organization
    ZHD
    Zonal Health Department
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 11, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Outbreak investigation of Visceral Leishmaniasis in Borena Zone, Oromia Region, Ethiopia, November 2019: Case Control study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Outbreak investigation of Visceral Leishmaniasis in Borena Zone, Oromia Region, Ethiopia, November 2019: Case Control study
    Belay Regassa, Negussie Deyessa, Adamu Addissie, Abdulnasir Abagero, Gemechu Shumi, Gemechu Gudina
    medRxiv 2020.11.02.20222869; doi: https://doi.org/10.1101/2020.11.02.20222869
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Outbreak investigation of Visceral Leishmaniasis in Borena Zone, Oromia Region, Ethiopia, November 2019: Case Control study
    Belay Regassa, Negussie Deyessa, Adamu Addissie, Abdulnasir Abagero, Gemechu Shumi, Gemechu Gudina
    medRxiv 2020.11.02.20222869; doi: https://doi.org/10.1101/2020.11.02.20222869

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)